Ongoing and Future Clinical Trials of Device Therapies for Patients with Heart Failure.

Cardiac failure clinical trials future

Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
17 Aug 2024
Historique:
received: 14 08 2024
accepted: 16 08 2024
medline: 20 8 2024
pubmed: 20 8 2024
entrez: 19 8 2024
Statut: aheadofprint

Résumé

Heart failure continues to pose a significant burden in terms of morbidity, mortality, and healthcare costs worldwide despite the implementation of guideline-directed medical therapy. Addressing this challenge and improving clinical outcomes for this patient population remains an urgent priority. Recognizing the limitations in current medical approaches and exploring strategies to overcome these limitations are crucial steps toward improving future outcomes. Various device-based interventions, such as Cardiac Resynchronization Therapy devices and Left Ventricular Assist Devices, have demonstrated notable benefits for individuals with heart failure. Our review is aimed at summarizing the ongoing research into new device therapies for heart failure, emphasizing their potential to overcome the current challenges in treatment. By utilizing Clinicaltrials.gov, an online repository, we conducted a comprehensive search for trials investigating emerging device therapies for patients dealing with heart failure.

Identifiants

pubmed: 39159710
pii: S0146-2806(24)00440-7
doi: 10.1016/j.cpcardiol.2024.102805
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102805

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Subaina Naeem Khalid (SN)

Department of Internal Medicine, SUNY Upstate Medical University.

Taha Mansoor (T)

Department of Internal Medicine, Western Michigan University Homer Stryker M.D. School of Medicine. Electronic address: taha.mansoor@wmed.edu.

Muhammad Ibraiz Bilal (MI)

Department of Internal Medicine, Allegheny Health Network.

Sardar Hassan Ijaz (SH)

Division of Cardiology, Hartford Hospital CT, USA.

Marat Fudim (M)

Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

Stephen J Greene (SJ)

Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

Vijay Nambi (V)

Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA; Michael E. DeBakey Veterans Affair Medical Center.

Salim S Virani (SS)

Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA; Department of Medicine, Aga Khan University, Karachi, Pakistan; Texas Heart Institute, Houston, TX.

Gregg C Fonarow (GC)

Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles CA, USA.

Dmitry Abramov (D)

Division of Cardiology, Department of Medicine, Loma Linda University Health, Loma Linda, CA, USA.

Abdul Mannan Khan Minhas (AMK)

Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA.

Classifications MeSH